Immuron Ltd (ASX:IMC) Share Price & Analysis
(ASX:IMC) Share Price Chart
About (ASX: IMC)
Immuron Limited is an Australian biopharmaceutical company that specializes in developing innovative therapeutic solutions using a unique proprietary technology platform. The company focuses on creating specifically targeted polyclonal antibodies derived from hyper-immune bovine colostrum, which can address significant unmet medical needs across various health domains.
The company’s core technology centers on producing patent-protected immunoglobulins (IgG) that can be applied to gastrointestinal health, immune defense, and other critical medical applications. Their product portfolio includes Travelan®, designed to reduce the risk of travelers’ diarrhea, and Protectyn®, which supports healthy gut and liver function. These products demonstrate the practical medical applications of their sophisticated antibody development platform.
Immuron has established credibility through strategic partnerships with renowned institutions like the Walter Reed Army Institute of Research, National Institutes of Health, CSIRO, and several prominent universities. As a publicly listed company traded on both the Australian Securities Exchange (ASX: IMC) and NASDAQ (IMRN), Immuron is positioned at the intersection of scientific innovation and commercial development, committed to advancing novel therapeutic solutions that can improve human health outcomes.